Posted inWire
Merck to acquire Cidara Therapeutics for $9.2 billion
SAN DIEGO - Merck & Co Inc (NYSE: MRK), known as MSD outside the U.S. and Canada, said on Saturday it will acquire Cidara Therapeutics Inc (Nasdaq: CDTX) in a…
Posted inLondon Stock Exchange
Biogen acquires Alcyone Therapeutics for $85 million
LONDON: RTW Biotech Opportunities Ltd, the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, announced that Biogen Inc. has…
Posted inIndices and commodities
Tech titans lift Nasdaq to record before market pullback
Dow Jones drops 131 points despite blockbuster results from Microsoft and Meta; broader market struggles amid Fed uncertainty and tariff tensions U.S. stocks seesawed Thursday as the S&P 500 and…
Posted inWire
Merck signs $610 million deal to acquire Caraway Therapeutics
LONDON, UK: Merck, a global leader in biopharmaceuticals, has announced that it has entered into a definitive agreement to acquire Caraway Therapeutics, Inc., a company specialized in developing novel, small-molecule…
Posted inWire
Merck appoints Deborah H. Telman as General Counsel for Organon & Co
KENILWORTH: Merck, known as MSD outside the United States and Canada, announced the appointment of Deborah H. Telman as General Counsel for Organon & Co., its intended spinoff of its…
Posted inSingapore Exchange
Merck to develop AnteoBind-activated Europium particle products
BRISBANE: AnteoTech Ltd has signed a non-binding Heads of Agreement with Merck to co-develop AnteoBind activated Europium particles for the rapidly growing global point of care (PoC) diagnostic testing market.…